A5063383350- Psoriasis: Treatment and Pathogenesis
- Dermatological and COVID-19 studies
- Autoimmune Bullous Skin Diseases
- Dermatology and Skin Diseases
- Pregnancy-related medical research
- Hidradenitis Suppurativa and Treatments
- Systemic Sclerosis and Related Diseases
- COVID-19 Clinical Research Studies
- Inflammatory Bowel Disease
- Cancer Immunotherapy and Biomarkers
- Autoimmune and Inflammatory Disorders
- Pregnancy and preeclampsia studies
- Skin and Cellular Biology Research
- Pregnancy and Medication Impact
- Lymphatic System and Diseases
- Healthcare professionals’ stress and burnout
- Neonatal skin health care
- Body Contouring and Surgery
- Polyomavirus and related diseases
- Plant Pathogens and Fungal Diseases
- Global Health Care Issues
- Immunotoxicology and immune responses
- Posttraumatic Stress Disorder Research
- Epigenetics and DNA Methylation
- Urticaria and Related Conditions
Postgraduate School of Molecular Medicine
2024
Central Clinical Hospital
2020-2024
Ministry of Interior and Administration
2021-2024
Medical University of Warsaw
2015-2020
Dermal lesions in IBD patients treated with anti-TNF -α 1 their classification is based on pathophysiology and relationship the underlying disease. 7,8Currently, many drugs are used treatment of IBD, main goal to reduce inflammation. 9 -12The best -known group biologic anti-tumor necrosis factor α (anti-TNF -α) antibodies, specifically infliximab INTROduCTION Patients inflammatory bowel disease (IBD), such as Crohn (CD) ulcerative colitis (UC), may experience extraintestinal symptoms.Skin...
The main goal of the study was to determine whether uncomplicated pregnancy and natural labor exert influence on cornea anterior chamber eye.The included 114 eyes 57 women in age 21-35 years old. Only patients physiological giving birth were recruited into study. Prospective observative examination performed. Patients diagnosed twice: 36 HBD 6 weeks after labor. Using Scheimpflug camera (Pentacam system) following parameters assessed: central corneal thickness (CCT), keratometric parameters:...
Currently, a very important thread of research on COVID-19 is to determine the dimension psychopathological emotional reactions induced by pandemic. A non-experimental online project was designed predictors severity symptoms, such as depression and PTSD nature feedback mechanism between them in groups men, remaining hospital isolation due infection at-home during epidemic. The presence symptoms depression, post-traumatic stress disorder (PTSD) sense threat pandemic were assessed using...
The present multi-center, long-term, real-life study made an attempt to assess the efficacy of risankizumab in treatment moderate-to-severe plaque psoriasis. comprised 185 patients from 10 Polish dermatologic departments undergoing treatment. disease severity was measured using Psoriasis Area and Severity Index (PASI) before start next at defined timepoints, i.e., 4, 16, 28, 40, 52 96 weeks percentage achieving PASI90 PASI100 responses as well PASI decrease timepoints were calculated,...
Biologics are used for the treatment of patients with moderate to severe psoriasis. According recommendations major global dermatological associations, who had not reported clinical symptoms or close contact a confirmed/probable COVID-19 case in last 14 days can continue biologic therapy.The aim our study was determine prevalence SARS-CoV-2 infection, its manifestations and influence on course underlying disease psoriasis aggressive psoriatic arthritis undergoing therapy.All 61 treated...
The aim of the study was to investigate prevalence self-reported skin complaints during pregnancy, applied treatment and impact on well-being pregnant women.We asked 1935 women that were maximum 4 years after labor fill in our questionnaire. questionnaire included questions concerning course observed lesions, influence quality life.Skin changes pregnancy reported by 1447 patients (74.78%). as follows: stretch marks (77.4%), acne (21.6%) recurrent herpes labialis (11.6%). In 43.67% (n = 632)...
Infliximab (IFX) is a monoclonal antibody that binds to and neutralizes TNF-α. IFX (Remicade) was approved by the U.S. Food Drug Administration in 2006 for treatment of severe plaque psoriasis. In 2013 two infliximab biosimilars: Remsima Inflectra were also registered. The introduction biosimilar drugs associated with significant reduction costs.To evaluate efficacy non-medical switch option patients psoriasis under drug program "Treatment moderate psoriasis" Ministry Health Poland.The group...
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Ciechanowicz P, Lewandowski K, Szymańska E, Kaniewska M, Rydzewska G, Walecka I. Skin and gastrointestinal symptoms in COVID-19. Gastroenterology Review/Przegląd Gastroenterologiczny. 2020;15(4):301-308. doi:10.5114/pg.2020.101558. APA Ciechanowicz, P., Lewandowski, K., Szymańska, E., Kaniewska, M., Rydzewska, G., & Walecka, (2020). Gastroenterologiczny, 15(4), 301-308. https://doi.org/10.5114/pg.2020.101558...
Abstract Background Oncological anxiety associated with biological therapy is a common challenge in inflammatory bowel disease (IBD) and it have raised questions about the need for dermatological assessment of skin before starting to exclude cutaneous malignancies. Methods The aim study was assess frequency cancers IBD patients therapy. We conducted retrospective, single-centre evaluation on cancers. Results A group who were referred qualification treatment consisted n = 805 patients, out...
1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5. CrossRef Google Scholar
: Oncological anxiety associated with biological therapy is a particular challenge in inflammatory bowel disease (IBD), and it has raised questions about the need for dermatological assessment of skin before starting therapy.
The COVID-19 pandemic spread to almost all countries in the world within a few months, necessitating changes medical care for patients with SARS-CoV-2 infections as well various chronic diseases. Ensuring safety of staff and hospitals specializing infectious diseases is major logistical challenge. Psoriasis treated immunosuppressive medications, including those under biologic therapy, are special group. Many scientific societies do not recommend discontinuing therapy without symptoms or...
Biological agents: TNF-α inhibitors, IL-12, and IL-23 blockers, IL-17 inhibitors are used in the treatment of plaque psoriasis. Adalimumab (ADA) is an antibody that binds to TNF-α. Ustekinumab (UST) blocks IL-12 IL-23. The data obtained from medical records exceptional value. aim study was evaluate efficacy ADA UST during a single 40-week period biological patients under drug program "Treatment moderate severe form psoriasis." group 620 adult with psoriasis, who were unresponsive or had...